Pseudophakic Macular Edema (Irvine-Gass Syndrome): Has the Treatment Changed?

¹Ophthalmology Department, Santa Maria University Hospital, Portugal.

Corresponding Author: Ivo Filipe Gama, Department of Ophthalmology, Santa Maria University Hospital. Faculty of Medicine of the University of Lisbon, Lisbon, Portugal. Tel: +351 21 796 7624; E-Mail: [email protected]

Received Date: 13 Apr 2016   
Accepted Date: 12 Jul 2016   
Published Date: 19 Jul 2016

Copyright © 2016 Gama IF

Citation: Gama IF. (2016). Pseudophakic Macular Edema (Irvine-Gass syndrome): Has the Treatment Changed?. Mathews J Ophthalmol. 1(1): 004.

INTRODUCTION

Cataract surgery is the most common ophthalmic surgery and is generally associated with good visual outcomes. Nevertheless, cystoid macular edema may develop resulting in suboptimal visual results. The post-surgical macular edema (PSME) is one of the most important causes of suboptimal visual acuity that can occur after any intraocular surgery, even in uncomplicated cases, namely cataract surgery. In this setting, it is also called Irvine-Gass syndrome (IGS) or pseudophakic cystoid macular edema (PCME).